EGEliza Gil

Eliza Gil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eliza Gil has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Streptococcus anginosus group as a cause of serious streptococcal infection in the UK: a retrospective population-based surveillance study

    by Eliza Gil, James Hatcher, Sophia De Saram, Trupti Patel, Theresa Lamagni, Rebecca Guy, Michael Marks, Jeremy Brown


  • Open Access

    Management of community-acquired brain abscess and intracranial empyema: a survey of UK neurosurgical centres

    by Carmen Thompson Perea, Holly Roy, James Hatcher, Sophia de Saram, Jacob Bodilsen, Peter Whitfield, William Singleton, Jack Wildman, Michelle M. Kameda-Smith, Eliza Gil

    Purpose: We sought to describe current perceptions and attitudes to management of of brain abscess (BA) or sub-/extra-dural empyema (SDE/EDE) in the United Kingdom (UK) to compare this to the 2024 European Society of Clinical Microbiology and Infectious Diseases BA guidelines. Methods: We conducted a web-based survey of infection specialists (IS) and neurosurgeons (NS) at neurosurgical centres across the UK. Results: IS from 27/39 (69%) and NS from 18/39 (46%) UK neurosurgical centres participated. All IS reported use of a third-generation cephalosporin as empirical antibiotic therapy, 57/61 (93%) alongside metronidazole, 19/57 (33%) preferring oral metronidazole throughout treatment. Most IS (46/60, 76.7%) consider switching to oral antibiotics prior to completing 6 weeks intravenous (IV) therapy, with 33/46 (71.7%) considering a 1–2 week minimum IV duration if there has been neurosurgical intervention. Most NS (22/25, 88%) agreed that neurosurgical intervention is indicated for any BA ≥ 2.5 cm diameter, most (21/25, 84%) favouring burr hole aspiration. For SDE/EDE only 12/25 (48%) of NS would surgically intervene in all circumstances. Most IS and NS (72/76, 94.7%) would consider intrathecal antibiotics in ruptured BA with ventriculitis; only 11/74 (14%) reported experience with intracavitary antimicrobials. 44/74 (59%) reported using steroids in BA, while 20/74 (27%) reported avoiding steroids. Reimaging was favoured at 2–3 weeks by NS, IS favoured 4–8 weeks, or not reimaging. Conclusion: There are areas of marked variation in the management of BA and SDE/EDE in the UK, particularly early switch from IV to oral antibiotics, SDE surgery, repeat brain imaging and use of steroids.


  • Open Access

    Streptococcus intermedius : an underestimated pathogen in brain infection?

    by Eliza Gil, James Hatcher, Sophia de Saram, Rebecca L Guy, Theresa Lamagni, Jeremy S Brown

    Streptococcus intermedius is an oral commensal organism belonging to the Streptococcus anginosus group (SAG). S. intermedius causes periodontitis as well as invasive, pyogenic infection of the central nervous system, pleural space or liver. Compared with other SAG organisms, S. intermedius has a higher mortality as well as a predilection for intracranial infection, suggesting it is likely to possess virulence factors that mediate specific interactions with the host resulting in bacteria reaching the brain. The mechanisms involved are not well described. Intracranial suppuration (ICS) due to S. intermedius infection can manifest as an abscess within the brain parenchyma, or a collection of pus (empyema) in the sub- or extra-dural space. These infections necessitate neurosurgery and prolonged antibiotic treatment and are associated with a considerable burden of morbidity and mortality. The incidence of ICS is increasing in several settings, with SAG species accounting for an increasing proportion of cases. There is a paucity of published literature regarding S. intermedius pathogenesis as well as few published genomes, hampering molecular epidemiological research. This perspective evaluates what is known about the clinical features and pathogenesis of ICS due to S. intermedius and explores hypothetical explanations why the incidence of these infections may be increasing.


  • Open Access

    Increasing rhinovirus prevalence in paediatric intensive care patients since the SARS-CoV2 pandemic

    by Eliza Gil, Sunando Roy, Tim Best, James Hatcher, Judith Breuer


  • Open Access

    Streptococcus pneumoniae meningitis and the CNS barriers

    by Eliza Gil, Emma Wall, Mahdad Noursadeghi, Jeremy S. Brown

    Streptococcus pneumoniae (SPN) is a globally significant cause of meningitis, the pathophysiology of which involves damage to the brain by both bacterial virulence factors and the host inflammatory response. In most cases of SPN meningitis bacteria translocate from the blood into the central nervous system (CNS). The principal site of SPN translocation into the CNS is not known, with possible portals of entry proposed to be the cerebral or meningeal blood vessels or the choroid plexus. All require SPN to bind to and translocate across the vascular endothelial barrier, and subsequently the basement membrane and perivascular structures, including an additional epithelial barrier in the case of the blood-CSF barrier. The presence of SPN in the CNS is highly inflammatory resulting in marked neutrophilic infiltration. The secretion of toxic inflammatory mediators by activated neutrophils within the CNS damages pathogen and host alike, including the non-replicative neurons which drives morbidity and mortality. As with the translocation of SPN, the recruitment of neutrophils into the CNS in SPN meningitis necessitates the translocation of neutrophils from the circulation across the vascular barrier, a process that is tightly regulated under basal conditions – a feature of the ‘immune specialization’ of the CNS. The brain barriers are therefore central to SPN meningitis, both through a failure to exclude bacteria and maintain CNS sterility, and subsequently through the active recruitment and/or failure to exclude circulating leukocytes. The interactions of SPN with these barriers, barrier inflammatory responses, along with their therapeutic implications, are explored in this review.


  • Open Access

    Pericyte derived chemokines amplify neutrophil recruitment across the cerebrovascular endothelial barrier

    by Eliza Gil, Cristina Venturini, David Stirling, Carolin Turner, Liku B. Tezera, Giuseppe Ercoli, Tina Baker, Katharine Best, Jeremy S. Brown, Mahdad Noursadeghi

    Excessive neutrophil extravasation can drive immunopathology, exemplified in pyogenic meningitis caused byStreptococcus pneumoniaeinfection. Insufficient knowledge of the mechanisms that amplify neutrophil extravasation has limited innovation in therapeutic targeting of neutrophil mediated pathology. Attention has focussed on neutrophil interactions with endothelia, but data from mouse models also point to a role for the underlying pericyte layer, as well as perivascular macrophages, the only other cell type found within the perivascular space in the cerebral microvasculature. We tested the hypothesis that human brain vascular pericytes (HBVP) contribute to neutrophil extravasation in a transwell model of the cerebral post-capillary venule. We show that pericytes augment endothelial barrier formation. In response to inflammatory cues, they significantly enhance neutrophil transmigration across the endothelial barrier, without increasing the permeability to small molecules. In our model, neither pericytes nor endothelia responded directly to bacterial stimulation. Instead, we show that paracrine signalling by multiple cytokines from monocyte derived macrophages drives transcriptional upregulation of multiple neutrophil chemokines by pericytes. Pericyte mediated amplification of neutrophil transmigration was independent of transcriptional responses by endothelia, but could be mediated by direct chemokine translocation across the endothelial barrier. Our data support a model in which microbial sensing by perivascular macrophages generates an inflammatory cascade where pericytes serve to amplify production of neutrophil chemokines that are translocated across the endothelial barrier to act directly on circulating neutrophils. In view of the striking redundancy in inflammatory cytokines that stimulate pericytes and in the neutrophil chemokines they produce, we propose that the mechanism of chemokine translocation may offer the most effective therapeutic target to reduce neutrophil mediated pathology in pyogenic meningitis.


  • Open Access

    Streptococcus pneumoniae interactions with the complement system

    by Eliza Gil, Mahdad Noursadeghi, Jeremy S. Brown

    Host innate and adaptive immunity to infection withStreptococcus pneumoniaeis critically dependent on the complement system, demonstrated by the high incidence of invasiveS. pneumoniaeinfection in people with inherited deficiency of complement components. The complement system is activated byS. pneumoniaethrough multiple mechanisms. The classical complement pathway is activated by recognition ofS. pneumoniaeby C-reactive protein, serum amyloid P, C1q, SIGN-R1, or natural or acquired antibody. SomeS. pneumoniaestrains are also recognised by ficolins to activate the mannose binding lectin (MBL) activation pathway. Complement activation is then amplified by the alternative complement pathway, which can also be activated byS. pneumoniaedirectly. Complement activation results in covalent linkage of the opsonic complement factors C3b and iC3b to theS. pneumoniaesurface which promote phagocytic clearance, along with complement-mediated immune adherence to erythrocytes, thereby protecting against septicaemia. The role of complement for mucosal immunity toS. pneumoniaeis less clear. Given the major role of complement in controlling infection withS. pneumoniae, it is perhaps unsurprising thatS. pneumoniaehas evolved multiple mechanisms of complement evasion, including the capsule, multiple surface proteins, and the toxin pneumolysin. There is considerable variation betweenS. pneumoniaecapsular serotypes and genotypes with regards to sensitivity to complement which correlates with ability to cause invasive infections. However, at present we only have a limited understanding of the main mechanisms causing variations in complement sensitivity betweenS. pneumoniaestrains and to non-pathogenic streptococci.


  • Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV

    by Eliza Gil, Nicola Sweeney, Veronica Barrett, Stephen Morris-Jones, Robert F. Miller, Victoria J. Johnston, Michael Brown

    Nontuberculous mycobacteria can cause disseminated infections in immunocompromised patients and are challenging to treat because of antimicrobial resistance and adverse effects of prolonged multidrug treatment. We report successful treatment with bedaquiline, a novel antimycobacterial drug, as part of combination therapy for 2 patients with disseminated nontuberculous mycobacteria co-infected with HIV.


  • Open Access

    Letter in response to ‘Modelling SARS-COV2 spread in London: Approaches to lift the lockdown’ local experience, national questions. How local is local enough?

    by Eliza Gil, Sophie Weller, Sakib Rokadiya, Mariyam Mirfenderesky, Aliko Ahmed, Achim Schwenk